SCHEMBL158299

SCHEMBL158299

NC(=O)CC(O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3056738 1.00
SCHEMBL18902875 1.00
SCHEMBL8087904 0.97 LMNA (0.33)
SCHEMBL31040601 0.97 LMNA (0.33)
Glycine SCHEMBL9703259 0.87 GLRA1 (0.48)
Succinic Acid SCHEMBL8578421 0.87 LMNA (0.43)
Glycine SCHEMBL9394864 0.87 GLRA1 (0.48)
Acrylic Acid SCHEMBL29610169 0.83 LMNA (0.43)
Ether SCHEMBL8376136 0.83 ALOX15 (0.36)
SCHEMBL2163096 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242715-A1 METHOD FOR RAPIDLY PROVIDING PYRIDAZINES FROM TETRAZINES AND CIS-DIENOPHILES TETRAKIT TECHNOLOGIES APS (DK) 2025-11-27 WO claimed
WO-2025044924-A1 RADIOPHARMACEUTICAL TARGETING CARBONIC ANHYDRASE 无锡诺宇医药科技有限公司 2025-03-06 WO claimed
EP-4493061-A2 CATALYTIC REACTIVE OXYGEN SPECIES SCAVENGER HYDROGEL Senseonics, Incorporated (US) 2025-01-22 EP claimed
US-20240401095-A9 CONVERSION OF WASTE PLASTICS TO HIGH-VALUE METABOLITES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2024-12-05 US claimed
US-20240150803-A1 CONVERSION OF WASTE PLASTICS TO HIGH-VALUE METABOLITES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2024-05-09 US claimed
CN-115838368-B Hydroxamic acid compound and derivative thereof, preparation method, pharmaceutical composition and application 中国药科大学 2024-02-27 CN claimed
CN-116903581-A SHP2/HDAC double-target inhibitor and preparation method and application thereof 山东大学 2023-10-20 CN claimed
US-20230293064-A1 CATALYTIC REACTIVE OXYGEN SPECIES SCAVENGER HYDROGEL SENSEONICS, INCORPORATED (US) 2023-09-21 US claimed
WO-2023178170-A2 CATALYTIC REACTIVE OXYGEN SPECIES SCAVENGER HYDROGEL SENSEONICS, INCORPORATED (US) 2023-09-21 WO claimed
CN-111116312-B Method for preparing 1,2,4-butanetriol through catalytic hydrogenation 中国科学院青岛生物能源与过程研究所 2022-10-28 CN claimed
WO-2000004892-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2000-02-03 WO claimed
WO-1998052910-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-11-26 WO claimed
EP-0821666-A1 DERIVATIVES OF SUCCINAMIDE AND THEIR USE AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-02-04 EP claimed
EP-0578145-B1 Compounds and process for photoactivable labelling of biomolecules HOFFMANN LA ROCHE (CH) 1997-10-29 EP claimed
EP-0758887-A1 MULTIFUNCTIONAL LIGAND FOR USE AS A DIAGNOSTIC OR THERAPEUTIC PHARMACEUTICAL CURATORS OF THE UNIVERSITY OF MISSOURI (US) 1997-02-26 EP claimed
WO-1996033161-A1 DERIVATIVES OF SUCCINAMIDE AND THEIR USE AS METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1996-10-24 WO claimed
WO-1995029669-A2 MULTIFUNCTIONAL LIGAND FOR USE AS A DIAGNOSTIC OR THERAPEUTIC PHARMACEUTICAL CURATORS OF THE UNIVERSITY OF MISSOURI (US) 1995-11-09 WO claimed
EP-0562054-A4 1994-04-27 EP claimed
EP-0562054-A1 MULTIFUNCTIONAL LIGAND FOR USE AS A DIAGNOSTIC OR THERAPEUTIC PHARMACEUTICAL THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 1993-09-29 EP claimed
WO-1992019573-A2 MULTIFUNCTIONAL LIGAND FOR USE AS A DIAGNOSTIC OR THERAPEUTIC PHARMACEUTICAL THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 1992-11-12 WO claimed